
Loading, please wait...

Loading, please wait...

Obstructive sleep apnea (OSA) remains a major health challenge globally and in India. While positive airway pressure (PAP) is the gold standard, many patients struggle with adherence. Hypoglossal nerve stimulation (HGNS) offers a viable alternative for these individuals. However, clinicians often face difficulty predicting the HGNS response in OSA before implantation. Recent research suggests that pre-operative imaging of upper airway anatomy could hold the key to better patient selection.
Initially, researchers conducted a prospective cohort study to analyze how specific anatomical traits influence surgical outcomes. They focused on adults with moderate to severe OSA who were intolerant to traditional PAP therapy. Consequently, the team used standardized computed tomography (CT) protocols to measure tongue size and the surrounding craniofacial framework. These measurements provide a more detailed view than traditional bedside assessments. Furthermore, the study used the Sher criteria to define success, requiring a significant reduction in the apnea-hypopnea index (AHI).
Notably, the research highlighted that tongue volume and its relationship to the mandible are critical factors. Patients with specific tongue-to-maxilla ratios showed a higher likelihood of positive outcomes. In contrast, those with disproportionate soft tissue volumes compared to their skeletal structure faced a higher risk of treatment failure. Additionally, the size of the retropalatal space influenced how effectively the tongue moved during stimulation. Therefore, evaluating these dimensions helps surgeons anticipate whether the airway will remain open during sleep.
Moreover, these findings suggest that a "one-size-fits-all" approach to HGNS is insufficient. Because more than one-third of patients currently experience suboptimal results, refined screening is essential. Specifically, integrating CT-based anatomical quantification into the preoperative workflow could improve the overall success rate. This evidence-based approach allows for more personalized treatment plans. As a result, healthcare providers can offer HGNS to the candidates most likely to benefit, reducing the burden of ineffective surgeries.
Overall, upper airway anatomy plays a decisive role in therapeutic efficacy. Tongue size and craniofacial metrics are not just secondary details; they are primary drivers of success. Clinicians should consider these objective imaging markers alongside patient history. Ultimately, this integration will lead to more predictable and robust improvements in sleep quality and long-term health outcomes for OSA patients.
HGNS is an implantable medical device that stimulates the hypoglossal nerve to move the tongue forward during sleep. This action prevents the tongue from collapsing and blocking the airway.
The device relies on moving physical structures. If the tongue is excessively large or the jaw structure is too small, the stimulation might not create enough space to keep the airway open effectively.
While no test is 100% certain, CT scans provide detailed measurements of tongue volume and airway space. These metrics help doctors identify if your specific anatomy is conducive to a successful outcome with HGNS.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This study examines how CT-derived anatomical measurements of the tongue and craniofacial structures influence the success of HGNS therapy in OSA patients....
5 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today